Overview

Oral Huzhang Granules for Acute Gouty Arthritis

Status:
Not yet recruiting

Trial end date:
2023-08-31

Target enrollment:

Participant gender:

Summary

We designed this study as a double-blind, randomized, controlled clinical trial. The aim of the study is to evaluate the clinical efficacy, safety and control of recurrence rate of acute gouty arthritis

Phase:

Phase 2

Details

Lead Sponsor:

Shanghai Yueyang Integrated Medicine Hospital

Treatments:

Etoricoxib